For the quarter ending 2025-09-30, UCLE made $595,305 in revenue. $94,846 in net income. Net profit margin of 15.93%.
| Income Statement | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Sales | 595,305 | 476,705 | 449,216 | 610,864 |
| Cost of sales | 296,163 | 127,788 | 518,346 | 138,315 |
| Gross profit | 299,142 | 348,917 | -69,130 | 472,549 |
| Selling, general and administrative expenses | 557,518 | 872,797 | 811 | 541,731 |
| Officer compensation | - | - | 25,000 | - |
| Professional fees | - | - | 64,891.5 | - |
| Payroll and related expense | - | - | 798,509.5 | - |
| Total operating expenses | 557,518 | 872,797 | 889,212 | 541,731 |
| Loss from operations | -258,376 | -523,880 | -958,342 | -69,182 |
| Interest expense | 69,269 | 36,352 | 54,390 | 41,735 |
| Other income | 475,000 | - | 563.5 | - |
| Total other income (expense) | 405,731 | -36,352 | -53,263 | -41,735 |
| Income/(loss) before provision for income taxes | 147,355 | -560,232 | -1,011,605 | -110,917 |
| Provision for income taxes | - | 0 | - | - |
| Net income/(loss) | 147,355 | -560,232 | -1,011,605 | -110,917 |
| Deemed dividend for down-round provision in warrants | - | 0 | - | - |
| Preferred stock dividends | 52,509 | 71,227 | 18,611.5 | - |
| Net income/(loss) attributed to common stockholders | 94,846 | -631,459 | -1,086,051 | -110,917 |
| Loss per shares - basic (in dollars per share) | 0 | -0.01 | -0.03 | 0 |
| Loss per shares - diluted (in dollars per share) | 0 | -0.01 | -0.03 | 0 |
| Weighted average shares outstanding - basic (in shares) | 63,535,458 | 57,309,903 | -89,174,029 | 47,913,673 |
| Weighted average shares outstanding - diluted (in shares) | 63,535,458 | 57,309,903 | -89,174,029 | 47,913,673 |
US NUCLEAR CORP. (UCLE)
US NUCLEAR CORP. (UCLE)